Heart Tissue Engineering is a cutting-edge interdisciplinary field that combines principles from engineering, biology, and medicine to develop methods for repairing or replacing damaged cardiac tissue. The goal is to create functional heart tissue in the laboratory that can be used for transplantation or to stimulate regeneration in the patient's own heart. This approach is particularly significant considering the limited regenerative capacity of the heart following injury, such as myocardial infarction. Researchers in heart tissue engineering focus on designing biomimetic scaffolds, often made of biocompatible materials, to support the growth and organization of cardiac cells. These scaffolds provide a structural framework for cells to adhere, proliferate, and differentiate into functional cardiac tissue. Cells used in heart tissue engineering include cardiomyocytes, which are responsible for contraction, and supportive cells like fibroblasts and endothelial cells. Bioreactors are employed to simulate physiological conditions, such as mechanical forces and electrical signals, promoting tissue maturation and functionality. Additionally, advances in stem cell technology contribute to a scalable and potentially personalized approach for generating cardiac cells for tissue engineering. Challenges in heart tissue engineering include achieving proper vascularization, ensuring electromechanical integration of engineered tissue with the recipient's heart, and addressing immune responses post-transplantation. While progress has been made in preclinical models, the translation of these strategies to clinical applications is an ongoing area of research. Heart tissue engineering holds promise for revolutionizing cardiac care by offering innovative solutions for heart repair and regeneration.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Will be updated soon...
Vasiliki E Kalodimou, European University-Cyprus Ltd, Cyprus
Title : Will be updated soon...
Nagy Habib, Imperial College London, United Kingdom
Title : Will be updated soon...
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : Advanced 3D tissue models: Pioneering tools for investigating health and disease
Lucie Bacakova, Institute of Physiology of the Czech Academy of Sciences, Czech Republic
Title : Developing iPSC-derived 3D Outer Blood-Retinal Barrier Disease Models of Choroideremia for Gene Therapy Evaluation
Aradhana Kasimsetty, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), United States